Vascular normalization by erianin unleashes CAR-T immunotherapy in glioblastoma
{{output}}
Aberrant tumor vasculature is a major barrier limiting the efficacy of immunotherapy, including chimeric antigen receptor T-cell (CAR-T) therapy in solid tumors, by restricting T cell infiltration and impairing their functional activity. Glioblastoma (GBM), on... ...
